全文获取类型
收费全文 | 13083篇 |
免费 | 1171篇 |
国内免费 | 233篇 |
专业分类
耳鼻咽喉 | 57篇 |
儿科学 | 266篇 |
妇产科学 | 105篇 |
基础医学 | 917篇 |
口腔科学 | 125篇 |
临床医学 | 1472篇 |
内科学 | 3684篇 |
皮肤病学 | 166篇 |
神经病学 | 338篇 |
特种医学 | 1093篇 |
外国民族医学 | 2篇 |
外科学 | 1419篇 |
综合类 | 1329篇 |
预防医学 | 1399篇 |
眼科学 | 82篇 |
药学 | 931篇 |
4篇 | |
中国医学 | 656篇 |
肿瘤学 | 442篇 |
出版年
2024年 | 36篇 |
2023年 | 369篇 |
2022年 | 531篇 |
2021年 | 862篇 |
2020年 | 730篇 |
2019年 | 791篇 |
2018年 | 752篇 |
2017年 | 500篇 |
2016年 | 468篇 |
2015年 | 509篇 |
2014年 | 991篇 |
2013年 | 971篇 |
2012年 | 677篇 |
2011年 | 712篇 |
2010年 | 480篇 |
2009年 | 498篇 |
2008年 | 583篇 |
2007年 | 558篇 |
2006年 | 433篇 |
2005年 | 356篇 |
2004年 | 265篇 |
2003年 | 240篇 |
2002年 | 187篇 |
2001年 | 185篇 |
2000年 | 135篇 |
1999年 | 125篇 |
1998年 | 143篇 |
1997年 | 147篇 |
1996年 | 96篇 |
1995年 | 100篇 |
1994年 | 92篇 |
1993年 | 70篇 |
1992年 | 89篇 |
1991年 | 75篇 |
1990年 | 65篇 |
1989年 | 59篇 |
1988年 | 51篇 |
1987年 | 58篇 |
1986年 | 48篇 |
1985年 | 66篇 |
1984年 | 67篇 |
1983年 | 43篇 |
1982年 | 44篇 |
1981年 | 41篇 |
1980年 | 26篇 |
1979年 | 23篇 |
1978年 | 23篇 |
1976年 | 22篇 |
1975年 | 18篇 |
1973年 | 18篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
《Cancer radiothérapie》2022,26(4):611-615
In order to provide more convenient irradiation regimens for patient comfort, radiation facility organization and health expenses, new hypofractionated protocols have been evaluated. Moderately (dose/fraction: 2.3 to 3 Gy), then ultra (dose/fraction: 5.2 to 6.1 Gy) hypofractionated irradiations were first validated. The current question is: is it possible to go forward using extreme hypofractionated regimens (EHR) based on 1 to 3 fractions. Different irradiation techniques are under investigation. However, brachytherapy remains the smartest way to deliver a high dose in a small volume. We report prospective and retrospective study results which evaluated EHR for breast and prostate brachytherapy. While oncological outcome and toxicity profile appear extremely encouraging for low-risk breast cancer after a 1 to 4 fractions (6.25 to 20 Gy/fraction), the use of a single fraction of 19 to 23 Gy appears debatable for prostate cancer. Brachytherapy represents an emblematic example of EHR but longer follow-up and more mature results are awaited in order to specify the right indications and refine the EQD2 calculation method including new biological and technical factors. 相似文献
2.
《Pancreatology》2022,22(8):1175-1180
BackgroundHepatic steatosis has been described as a common finding in adults following total pancreatectomy with islet autotransplantation (TPIAT) but it is unknown if this occurs in children and adolescents.ObjectivesTo define the frequency of post-TPIAT hepatic steatosis in a sample of children and adolescents and to identify clinical predictors of incident steatosis post-TPIAT.MethodsIn this prospective study, consecutive participants at least 1-month post-TPIAT underwent a liver MRI with proton density fat fraction (PDFF) and blood draw at our pediatric academic medical center between April 2021 and January 2022. Comparison clinical pre-TPIAT liver MRI or ultrasound and insulin use and graft function data were extracted from the medical record. T-tests were used for the comparison of means across continuous variables between participants with and without post-TPIAT steatosis.ResultsA total of 20 participants (mean: 13 ± 4 years; 12 female) were evaluated. Mean liver PDFF at research MRI was 7.4 ± 6.2% (range: 2–25%). Seven participants (35%) had categorical hepatic steatosis (PDFF>5%) post-TPIAT, five of whom had pre-TPIAT steatosis, reflecting a 13% (2/15; 95% CI: 2–40%) incidence of post-TPIAT steatosis. Participant characteristics were not significantly different between subgroups with and without post-TPIAT steatosis. Mean PDFF at research MRI was not different between graft function subgroups (7.5% optimal/good vs. 7.3% marginal/failure; p = .96).ConclusionOur study shows a moderate prevalence but low incidence of hepatic steatosis in a small sample of children and adolescents post-TPIAT. This study raises questions about a causal relationship between TPIAT and hepatic steatosis. 相似文献
3.
4.
Gut bacteria and gut barrier plays important roles in body homeostasis. Ciprofloxacin (CPFX) is widely used to treat bacterial infections. However, whether high dosage of CPFX has side effects on gut barrier integrity is still unclear. Our results indicated that the High CPFX treatment (1 mg/ml) caused weight loss, nervousness, anorexia, and increased apoptosis cells in gut, but less influence was observed in the Low CPFX group (0.2 mg/ml). Meanwhile, the High CPFX treatment impaired tight junction molecules Ocln/ZO-1 level and down-regulated antibacterial genes expression (reg3γ, pla2g2α and defb1). Further, the High CPFX treatment increased pro-inflammatory cytokine IL-1β in intestinal tract, decreased IL-17A of duodenum but increased IL-17A of colon at day 37. In addition, the gut bacterial diversity and richness behaved significantly loss regarding CPFX treatment, especially in the High CPFX group during the experiment. Indole exhibited sharply decline in both Low and High CPFX groups at day 7, and the High CPFX mice needed longer time on restoring indole level. Meanwhile, CPFX treatment strongly decreased the concentrations of butyric acid and valeric acid at day 1. Correlation analysis indicated that the linked patterns between the key bacteria (families Bacteroidales_S247, Ruminococcaceae and Desulfovibrionaceae) and metabolites (indole and butyric acid) were disturbed via the CPFX treatment. In conclusion, the High CPFX treatment impaired the gut barrier with the evidence of reduced expression of tight junction proteins, increased apoptosis cells and inflammatory cells, decreased the bacterial diversity and composition, which suggesting a proper antibiotic-dosage use should be carefully considered in disease treatment. 相似文献
5.
6.
7.
8.
9.